Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology

Translate this page into:
[gtranslate]

Letter To Editor
1997:63:1;70-71
PMID: 20944275

Griseofulvin therapy in acne vulgaris

Surabhi Dayal, VK Jain
 Rohtak, India

Correspondence Address:
Surabhi Dayal
Rohtak
India
How to cite this article:
Dayal S, Jain V K. Griseofulvin therapy in acne vulgaris. Indian J Dermatol Venereol Leprol 1997;63:70-71
Copyright: (C)1997 Indian Journal of Dermatology, Venereology, and Leprology

To the Editor,

The idea of treating acne vulgaris with griseofulvin arose by chance, when a patient suffering from both tinea corporis and acne vulgaris was receiving griseofulvin. It was interesting to note that in the course of the treatment marked improvement occurred in acne lesions. Thus we planned to perform a clinical trial to find out the effect of griseofulvin in acne vulgaris.

Our trial included 20 patients having acne vulgaris. Out of 20 patients, 11 were males and 9 were females, their age ranging from 16-28 years. At the first visit patients were examined and number of inflammed acne lesions (papules, pustules, cysts and nodules) and non-inflammed acne lesions (comedones) were counted. Then griseofulvin 250 mg twice daily was started and patients were routinely followed up every 2 weeks for a total of 8 weeks. At each follow up visit number of lesions were again counted to assess the effect of griseofulvin. Our results were as follows:

Both subjective and objective impovement in the condition of the patients started within 2 weeks following the commencement of griseofulvin therapy. After 8 weeks of therapy there was a statistically singnificant decrease in the number of papules (p<0.001). Similarly in all the patients the decrease in the number of pustules after 8 weeks of therapy with griseofulvin was statistically significant (p<0.01). But it was noted that the decrease in number of comedones, cysts and nodules before and after 8 weeks of therapy was not statistically significant.

Thus the maximum benefit was observed in inflammatory acne lesions. Improvement was slow and less dramatic in non-inflammed lesions. No serious side-effects were noted with griseofulvin.

It is difficult to conjecture the mode of action of griseofulvin in acne vulgaris. It has been suggested recently that pathogenesis of acne also involves immune mechanisms,[1] evidence of which includes the observation of complement component C3 in the walls of dermal blood vessels and basement membrane zone of acne lesions and demonstration of cell mediated immunity directed towards P acnes in patients with severe acne. Attraction and killing of leucocytes by comedonal components, the resultant inflammatory cascade and specific immunological events all contribute to the final appearance of inflammed acne lesions. Thus one factor may be that griseofulvin may act as an immunomodulator as Tamaki et al have shown that griseofulvin can be used as an immunomodulator.[2] But still the mode of action of griseofulvin in acne vulgaris is unclear and further double blind controlled studies are essential to confirm our observations.

References
1.
Arondt KA, Bowers KE, Anjali R, Chuttani AR. Acne. In: Manual of dermatologic therapeutics. 5th edn. Boston:Little Brown Company, 1995;3.
[Google Scholar]
2.
Tamaki K, Saitoh A, Yasaka N. Differential effect of griseofulvin on interferon-gamma-induced HLA-DR and intercellular adhesion molecule-1 expression of human keratinocytes. Br J Dermatol 1992;127:258-61.
[Google Scholar]
Show Sections